カテゴリ： GlobalData, アメリカ, 企業調査

InVivo Therapeutics Corp：企業の製品パイプライン分析2018

◆英語タイトル：InVivo Therapeutics Corp - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C12775
◆発行会社（調査会社）：GlobalData
◆発行日：2018年12月
◆ページ数：35
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
InVivo Therapeutics Corp (InVivo), a subsidiary of InVivo Therapeutics Holdings Corp, is a medical device company that offers therapeutic products. The company develops and commercializes groundbreaking treatments for spinal cord injuries. Its products include biocompatible neuro spinal scaffold to treat acute SCI, and a biocompatible neuro spinal scaffold plus stem cells to treat chronic. InVivo offers treatment for mechanical injury directly disrupts axons, blood vessels, and cell membranes; and compressive-contusive-type injuries. The company provides services in the field of spinal cord injury. Its pipeline products comprise neuro-spinal scaffold, and bioengineered neural trails. InVivo is headquartered in Cambridge, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InVivo Therapeutics Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
InVivo Therapeutics Corp Company Overview 5
InVivo Therapeutics Corp Company Snapshot 5
InVivo Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview 5
InVivo Therapeutics Corp – Pipeline Analysis Overview 7
InVivo Therapeutics Corp – Key Facts 7
InVivo Therapeutics Corp – Major Products and Services 8
InVivo Therapeutics Corp Pipeline Products by Development Stage 9
InVivo Therapeutics Corp Pipeline Products Overview 11
Dural Graft 11
Dural Graft Product Overview 11
Injectable Hydrogel – Fibrosis 12
Injectable Hydrogel – Fibrosis Product Overview 12
Injectable Hydrogel – Peripheral Nerve Pain 13
Injectable Hydrogel – Peripheral Nerve Pain Product Overview 13
Injectable Hydrogel Device – Acute SCI 14
Injectable Hydrogel Device – Acute SCI Product Overview 14
InVivoSeal 15
InVivoSeal Product Overview 15
Nerve Conduit 16
Nerve Conduit Product Overview 16
Neuro-Spinal Scaffold – Acute Complete Cervical SCI 17
Neuro-Spinal Scaffold – Acute Complete Cervical SCI Product Overview 17
Neuro-Spinal Scaffold – Acute Complete Thoracic SCI 18
Neuro-Spinal Scaffold – Acute Complete Thoracic SCI Product Overview 18
Neuro-Spinal Scaffold – Incomplete Thoracic & Cervical SCI 19
Neuro-Spinal Scaffold – Incomplete Thoracic & Cervical SCI Product Overview 19
Spinal Multi – Segmental Cell and Drug Delivery System 20
Spinal Multi – Segmental Cell and Drug Delivery System Product Overview 20
TrailMaker 21
TrailMaker Product Overview 21
InVivo Therapeutics Corp – Key Competitors 22
InVivo Therapeutics Corp – Key Employees 23
InVivo Therapeutics Corp – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
InVivo Therapeutics Corp, Recent Developments 25
May 02, 2018: InVivo Therapeutics Announces Presentation of Complete Six-Month Primary Endpoint Results from the INSPIRE Study of the Investigational Neuro-Spinal Scaffold in Acute Thoracic Complete Spinal Cord Injury 25
Mar 19, 2018: InVivo Therapeutics Announces Contemporary Thoracic SCI Registry Study (the “CONTEMPO Registry Study”) Findings 25
Mar 08, 2018: InVivo Therapeutics Receives FDA Approval for Pivotal, Randomized, Controlled Trial of the Neuro-Spinal Scaffold in Patients with Acute Spinal Cord Injury 26
Feb 05, 2018: InVivo Therapeutics Announces Appointment of Richard Toselli, M.D., as President and Chief Executive Officer 26
Jan 03, 2018: InVivo Therapeutics Announces Latest Results from INSPIRE and Provides Update on Proposed Clinical Path Forward 27
Oct 10, 2017: InVivo Therapeutics Announces Oral Platform Presentation at 2017 Congress of Neurological Surgeons Annual Meeting 27
Sep 05, 2017: InVivo Therapeutics Announces Publication in Neurosurgery of Lifetime Hospitalization Costs for Thoracic Spinal Cord Injury Patients by Severity Grade 28
Aug 28, 2017: InVivo Therapeutics Announces Strategic Corporate Restructuring 28
Jul 31, 2017: InVivo Therapeutics Announces Updates on the INSPIRE Study 28
Jul 12, 2017: InVivo Therapeutics Announces Stanford Medicine as New Site for INSPIRE Study 30
Appendix 32
Methodology 32
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
InVivo Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview 5
InVivo Therapeutics Corp Pipeline Products by Equipment Type 6
InVivo Therapeutics Corp Pipeline Products by Indication 6
InVivo Therapeutics Corp, Key Facts 7
InVivo Therapeutics Corp, Major Products and Services 8
InVivo Therapeutics Corp Number of Pipeline Products by Development Stage 9
InVivo Therapeutics Corp Pipeline Products Summary by Development Stage 10
Dural Graft - Product Status 11
Dural Graft - Product Description 11
Injectable Hydrogel - Fibrosis - Product Status 12
Injectable Hydrogel - Fibrosis - Product Description 12
Injectable Hydrogel - Peripheral Nerve Pain - Product Status 13
Injectable Hydrogel - Peripheral Nerve Pain - Product Description 13
Injectable Hydrogel Device - Acute SCI - Product Status 14
Injectable Hydrogel Device - Acute SCI - Product Description 14
InVivoSeal - Product Status 15
InVivoSeal - Product Description 15
Nerve Conduit - Product Status 16
Nerve Conduit - Product Description 16
Neuro-Spinal Scaffold - Acute Complete Cervical SCI - Product Status 17
Neuro-Spinal Scaffold - Acute Complete Cervical SCI - Product Description 17
Neuro-Spinal Scaffold - Acute Complete Thoracic SCI - Product Status 18
Neuro-Spinal Scaffold - Acute Complete Thoracic SCI - Product Description 18
Neuro-Spinal Scaffold - Incomplete Thoracic & Cervical SCI - Product Status 19
Neuro-Spinal Scaffold - Incomplete Thoracic & Cervical SCI - Product Description 19
Spinal Multi - Segmental Cell and Drug Delivery System - Product Status 20
Spinal Multi - Segmental Cell and Drug Delivery System - Product Description 20
TrailMaker - Product Status 21
TrailMaker - Product Description 21
InVivo Therapeutics Corp, Key Employees 23
Glossary 34

List of Figures
InVivo Therapeutics Corp Pipeline Products by Equipment Type 6
InVivo Therapeutics Corp Pipeline Products by Development Stage 9

★海外企業調査レポート[InVivo Therapeutics Corp：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • TV Asahi Corporation (9409)：企業の財務・戦略的SWOT分析
    TV Asahi Corporation (9409) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ALPCO Diagnostics-医療機器分野：企業M&A・提携分析
    Summary ALPCO Diagnostics (ALPCO) is a lifescience company that imports and distributes immunoassay based products. The company’s products include immunoassays, chemiluminescent assays, flow cytometry reagents, purified antibodies, recombinant proteins, and HPLC and MS-MS reagents. It also provides …
  • Air China Limited：企業の戦略・SWOT・財務情報
    Air China Limited - Strategy, SWOT and Corporate Finance Report Summary Air China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Halozyme Therapeutics Inc (HALO)：製薬・医療：M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • Personal Genome Diagnostics Inc：製品パイプライン分析
    Summary Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laborat …
  • Aarti Industries Ltd (AARTIIND)：企業の財務・戦略的SWOT分析
    Summary Aarti Industries Ltd (Aarti Industries) is a chemical company that manufactures and markets benzene based basic and intermediate chemicals. It offers chemicals, pharma products and surfactants including rubber chemicals, dyes and pigment intermediates; surfactant intermediates, pharmaceutica …
  • Majesco：企業の戦略・SWOT・財務情報
    Majesco - Strategy, SWOT and Corporate Finance Report Summary Majesco - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Eloro Resources Ltd (ELO)：企業の財務・戦略的SWOT分析
    Summary Eloro Resources Ltd (Eloro Resources) is a mining and minerals exploration and development company that offers mineral exploration and development services. The company acquires, explores and develops precious and base-metal resources properties across Quebec. It explores for titanium, silve …
  • Catholic United Financial：企業の戦略的SWOT分析
    Catholic United Financial - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Hero AG：企業の戦略・SWOT・財務分析
    Hero AG - Strategy, SWOT and Corporate Finance Report Summary Hero AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Aclaris Therapeutics Inc (ACRS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Aclaris Therapeutics Inc (Aclaris Therapeutics) is a dermatologist-led bio-pharmaceutical company which focuses on identifying, developing, and commercializing prescription drug products for unmet needs in aesthetic and medical dermatology as well as immunology. Its lead product, ESKATA, is …
  • GVK Power and Infrastructure Ltd (GVKPIL)：企業の財務・戦略的SWOT分析
    GVK Power and Infrastructure Ltd (GVKPIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Leap Therapeutics Inc (LPTX)：医療機器：M&Aディール及び事業提携情報
    Summary Leap Therapeutics Inc (Leap Therapeutics), formerly HealthCare Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company’s pipeline products include DKN-01, a humanized monoclonal antibody that targets the D …
  • Groupe PSA：企業の戦略・SWOT・財務情報
    Groupe PSA - Strategy, SWOT and Corporate Finance Report Summary Groupe PSA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cost Plus Inc：企業の戦略的SWOT分析
    Cost Plus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Oxford BioTherapeutics Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Oxford BioTherapeutics Ltd (OBT) is a clinical stage oncology company that develops antibody drug conjugates for the treatment of variety of cancers. The company’s product pipelines currently includes T-cell based IO therapies including check point modulators; NK cell based IO therapies such …
  • Compumedics Ltd (CMP)-医療機器分野：企業M&A・提携分析
    Summary Compumedics Ltd (Compumedics) is a medical device company that develops and commercializes computer-based medical products for recording and diagnostics market. The company designs, develops and commercializes computer aided medical diagnostic systems. Its product categories comprise sleep d …
  • Optus Inc：企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Orsted AS：発電所・企業SWOT分析
    Orsted AS - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • PTB Group Limited：企業の戦略・SWOT・財務情報
    PTB Group Limited - Strategy, SWOT and Corporate Finance Report Summary PTB Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆